233 related articles for article (PubMed ID: 11245059)
21. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
[TBL] [Abstract][Full Text] [Related]
22. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
24. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
25. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
[TBL] [Abstract][Full Text] [Related]
26. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
28. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
Berner BR; Tary-Lehmann M; Yonkers NL; Askari AD; Lehmann PV; Anthony DD
Cell Immunol; 2005 May; 235(1):29-38. PubMed ID: 16181618
[TBL] [Abstract][Full Text] [Related]
31. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
[TBL] [Abstract][Full Text] [Related]
32. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.
Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G
Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
Stancek D; Robenský J
Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
37. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis.
Musiani M; Zerbini ML; Muscari A; Puddu GM; Gentilomi G; Gibellini D; Gallinella G; Puddu P; La Placa M
Microbiologica; 1990 Jan; 13(1):35-41. PubMed ID: 2155375
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus.
Tsai YT; Chiang BL; Kao YF; Hsieh KH
Int Arch Allergy Immunol; 1995 Mar; 106(3):235-40. PubMed ID: 7888786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
